SAN FRANCISCO (Reuters) - Life-sciences and health investing, long shunned by venture-capital investors, is making a comeback. Several venture firms globally have each raised or are raising funds this ...

(Alliance News) - Venture Life Group PLC on Tuesday said it sold the Ultradex and Dentyl brands to Covestus Holdings Ltd for an enterprise value of up to GBP4.5 million in order to focus on its core ...

Venture Life ( (GB:VLG)) has shared an announcement. Venture Life Group has issued 201,500 new ordinary shares following the exercise of share options by employees, with the shares expected to be ...

Life sciences venture capitalists are fundraising at their slowest pace since before the Covid-19 pandemic, even though limited partner interest in the biomedical sector remains strong. Venture ...

Life sciences venture capital investment in the second quarter jumped 37 percent over the prior quarter on increased exit activity, according to a new report. Life sciences companies raised $2.1 ...

The latest announcement is out from Venture Life ( (GB:VLG)). Venture Life Group has confirmed that, as of 31 December 2025, it has 128,253,812 ordinary shares of 0.3 pence in issue, of which ...

Venture Life (GB:VLG) has released an update. Venture Life Group PLC has announced a change in voting rights, with MI Chelverton UK Equity Growth Fund reducing its stake from 5.84% to 4.84%, affecting ...

XGEN Venture, a leading venture capital firm specializing in life sciences investments, proudly announces the final closing of its XGEN Venture Life Sciences Fund. The fund has successfully raised ...